It takes approx. 7 years to diagnose a patient with a rare disease. With NEW CentoXome®, we can turn those years into days

Pediatric medicines are vital to the health and wellbeing of children. Nevertheless, a core principle in any pediatric drug development program is that “children should not be enrolled in a clinical study unless necessary to achieve an important pediatric public health need”. As such, the balance of risk and likely clinical benefits must be assessed and the child should not be adversely impacted by enrolment in the research study.